Article information
Full text is only aviable in PDF
Bibliografía
[1.]
T. Montemayor, I. Alfajeme, C. Escudero, J. Morera, L. Sánchez Agudo.
Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica,
[2.]
T. Montemayor, I. Alfajeme, C. Escudero, J. Morera, L. Sánchez Agudo.
Normativa sobre diagnóstico de la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 32 (1996), pp. 285-301
[3.]
N.M. Siafakas, P. Vermeire, N.B. Pride, P. Paoletti, J. Gibson, P. Howard, et al.
Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Eur Respir J, 8 (1995), pp. 1398-1420
[4.]
Society American Thoracic.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 152 (1995), pp. S77-S121
[5.]
G.L. Snider, J. Kleinreman, W.M. Thurlbeck, Z.H. Bengali.
The definition of emphysema: report of National Heart and Blood Institute, division of Lung Diseases, workshop.
Am Rev Respir Dis, 132 (1985), pp. 182-185
[6.]
American Thoracic Society.
Lung function testing: selection of reference values and interpretative strategies.
Am Rev Respir Dis, 144 (1991), pp. 1202-1218
[7.]
British Thoracic Society.
Guidelines for the management of chronic obstructive pulmonary disease.
Thorax, 52 (1997), pp. S1-S28
[8.]
B.R. Celli.
Monitoring the progression of chronic obstructive pulmonary disease: time for a new staging system.
Eur Respir Rev, 9 (1999), pp. 165-168
[9.]
B. Celli, C. Cote, M. Marín, M. Montes de Oca, C. Casanova, R. Méndez.
The SCORE: a new COPD staging system combining 6MWD, MRC dyspnea. FEV1 and PaO2 as predictor of health care resources utilization (HCUR).
Am J Respir Crit Care Med, 161 (2000), pp. A749
[10.]
V. Sobradillo, M. Miravitlles, C.A. Jiménez, R. Gabriel, J.L. Viejo, J.F. Masa, et al.
Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo.
Arch Bronconeumol, 35 (1999), pp. 159-166
[11.]
J.F. Masa, M. Miravitlles, C. Villasante, C.A. Jiménez, J.L. Viejo, L. Fernández-Fau, et al.
Underdiagnosis and geographical differences in COPD prevalence in Spain.
Am J Respir Crit Care Med, 159 (1999), pp. A921
[12.]
L. Biglino, B. Girón, R. Fernández.
Encuesta nacional de salud 1995,
[13.]
V. Sobradillo.
Enfermedad pulmonar obstructiva crónica. Enfoque actual.
EPOC perspectivas actuales, pp. 3-17
[14.]
Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Informe del Gabinete de Estudios Sociológicos Bernard Krief. SEPAR, (1995),
[15.]
P. Alonso.
Proyecto coste por proceso,
[16.]
M.G. Seneff, D.P. Wagner, R.P. Wagner, J.E. Zimmerman, W.A. Knaus.
Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.
Jama, 274 (1995), pp. 1852-1857
[17.]
J.C. Hogg, P.T. Macklem, W.M. Thurlbeck.
Site and nature of airway obstruction in chronic obstructive lung disease.
N Engl J Med, 278 (1968), pp. 1355-1360
[18.]
M.G. Cosio, H. Ghezzo, J.C. Hogg, R. Corbin, M. Loveland, J. Dosman, et al.
The relations between structural changes in small airways and pulmonary function tests.
N Engl J Med, 298 (1978), pp. 1277-1281
[19.]
R. Filkenstein, R.S. Fraser, H. Ghezzo, M.G. Cosio.
Alveolar inflammation and its relation to emphysema in smokers.
Am J Respir Crit Care Med, 152 (1995), pp. 1666-1672
[20.]
T.C. O'Shaughnessy, T.W. Ansari, N.C. Barnes, P.K. Jeffery.
Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.
Am J Respir Crit Care Med, 155 (1997), pp. 852-857
[21.]
M. Saetta, A. Di-Stefano, G. Turato, F.M. Facchini, L. Corbino, C.E. Mapp, et al.
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 822-826
[22.]
V.I. Peinado, J.A. Barberà, P. Abate, J. Ramírez, J. Roca, S. Santos, et al.
Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 159 (1999), pp. 1605-1611
[23.]
D.S. Robinson, Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A.M. Bentley.
Predominant TH2-like broncho-alveolar T-lymphocite population in atopic asthma.
N Engl J Med, 326 (1992), pp. 298-304
[24.]
M. Humbert, S.R. Durham, S. Ying, P. Kimmitt, J. Barkans, B. Assoufi.
IL-4 and IL-5 mRNA and protein in bronchial biopsies from atopic and non atopic asthma. Evidence against “intrinsic” asthma beign a distinct immunopathological entity.
Am J Respir Crit Care Med, 154 (1996), pp. 1497-1504
[25.]
V.M. Keatings, P.D. Collins, D.M. Scott, P.J. Barnes.
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Am J Respir Crit Care Med, 153 (1996), pp. 530-534
[26.]
A.T. Hill, D. Bayley, R.A. Stockley.
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.
Am J Respir Crit Care Med, 160 (1999), pp. 893-898
[27.]
M.R. Lang, G.W. Fiaux, M. Gilooly, J.A. Stewart, D.J.S. Hulmes, D. Lamb.
Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs.
Thorax, 49 (1994), pp. 319-326
[28.]
W. Timens, W. Coers, J.F.M. Van Straten, D.S. Postma.
Extracellular matrix and inflammation: a role of fibroblast-mediated tissue repair in the pathogenesis of emphysema.
Eur Respir Rev, 7 (1997), pp. 119-123
[29.]
W.D. Kim, D.H. Eidelman, J.L. Izquierdo, H. Ghezzo, M.P. Saetta, M.G. Cosio.
Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities.
Am Rev Respir Dis, 144 (1991), pp. 1385-1390
[30.]
J.A. Barberà, A. Riverola, J. Roca, J. Ramírez, P.D. Wagner, D. Ros, et al.
Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 149 (1994), pp. 423-429
[31.]
V.I. Peinado, J.A. Barberà, J. Ramírez, F.P. Gómez, J. Roca, L. Jover, et al.
Endothelial dysfunction in pulmonary arteries of patients with mild COPD.
Am J Physiol, 274 (1998), pp. L908-L913
[32.]
A.T. Dinh-Xuan, T.W. Higenbottam, C.A. Clelland, J. Pepke-Zaba, G. Cremona, A.Y. Butt, et al.
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease.
N Engl J Med, 324 (1991), pp. 1539-1547
[33.]
R. Pérez-padilla, J. Regalado, S. Vedal, P. Paré, R. Chapela, R. Sansores, et al.
Exposure to biomass smoke of chronic airway disease in Mexican women. A case-control study.
Am J Respir Crit Care Med, 154 (1996), pp. 701-706
[34.]
C. Fletcher, R. Peto.
The natural history of chronic airflow obstruction.
Brit Med J, 1 (1977), pp. 1645-1648
[35.]
N. Wolkove, E. Dajczman, A. Colacone, H. Kreisman.
The relationship between pulmonary function and dyspnea in obstructive lung disease.
Chest, 96 (1989), pp. 1247-1251
[36.]
G.A.V. Borg.
Psychophysical basis of perceived exertion.
Med Sci Sports Exerc, 14 (1982), pp. 377-381
[37.]
D.A. Mahler, D.H. Weinberg, C.K. Wells, A.R. Feinstein.
The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes.
Chest, 85 (1984), pp. 751-758
[38.]
D.A. Mahler, R.A. Rosiello, A. Harver, T. Lentine, J.F. McGovern, J.A. Daubenspeck.
Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease.
Am Rev Respir Dis, 165 (1987), pp. 1229-1233
[39.]
S. Kesten, K.R. Chapman.
Physician perceptions and management of COPD.
Chest, 104 (1993), pp. 254-258
[40.]
A.M.W.J. Schols, J. Slangen, L. Volovics, E.F.M. Wouters.
Weight loss in a reversible factor in the prognosis of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 1791-1797
[41.]
P.S. Burge, P.M. Calverley, J.M.E. Daniels.
The acute effects of oral prednisolone in patients with COPD in the ISOLDE trial: responders and non-responders.
Am J Respir Crit Care Med, 153 (1996), pp. A126
[42.]
J.D. Cooper, G.A. Patteson, R.S. Sundaresan, E.P. Trulock, R.D. Yusen, M.S. Pohl, et al.
Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema.
J Thorac Cardiovascular Surg, 112 (1996), pp. 1319-1329
[43.]
D.E. O'Donnell, M. Lam, K.A. Webb.
Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 158 (1998), pp. 1557-1565
[44.]
A.G.N. Agustí, J. Cotes, P.D. Wagner.
Responses to exercise in lung diseases.
Eur Respir Mon, 6 (1998), pp. 32-50
[45.]
E.M. Baarends, A.M.W.J. Schols, R. Mostert, E.F.M. Wouters.
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease.
Eur Respir J, 10 (1997), pp. 2807-2813
[46.]
G.T. Ferguson, E. Fernández, M.R. Zamora, M. Pomerantz, J. Buichholz, B.J. Make.
Improved exercise performance following lung volume reduction surgery for emphysema.
Am J Respir Crit Care Med, 157 (1998), pp. 1195-1203
[47.]
B. Togores, A.G.N. Agustí.
Trastornos respiratorios durante el sueño en la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 32 (1996), pp. 32-39
[48.]
N.J. Douglas, D.C. Flenley.
Breathing during sleep in patients with obstructive lung disease.
Am Rev Respir Dis, 141 (1990), pp. 1055-1070
[49.]
J.J. Connaughton, J.R. Catterall, R.A. Elton, J.R. Stradling, N.J. Douglas.
Do sleep studies contribute to the management of patients with severe chronic obstructive pulmonary disease?.
Am Rev Respir Dis, 138 (1988), pp. 341-344
[50.]
E.C. Fletcher, R.A. Luckekett, W. Goodnight, C.C. Miller, W. Quian, C. Costarangos-Galarza.
A double blind trial of nocturnal supplement oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mmHg.
Am Rev Respir Dis, 145 (1992), pp. 1070-1076
[51.]
W.M. Thurlbeck, G. Simon.
Radiographic appearance of the chest in emphysema.
Am J Roentgenol, 130 (1978), pp. 429-440
[52.]
C. Sanders.
The radiographic diagnosis of emphysema.
Radiol Clin North Am, 29 (1991), pp. 1019-1030
[53.]
K.G. Chetty, S.E. Brown, R.W. Light.
Identification of pulmonary hypertension in chronic obstructive pulmonary disease from routine chest radiographs.
Am Rev Respir Dis, 126 (1982), pp. 338-341
[54.]
D.M. Skillrid, K.P. Offord, R.D. Miller.
Higher risk of lung cancer in chronic pulmonary disease. A prospective matched case-controlled study.
Ann Intern Med, 105 (1986), pp. 503-507
[55.]
J.S. Klein, G. Gamsu, W.R. Webb, J.A. Golden, N.L. Muller.
High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity.
Radiology, 182 (1992), pp. 817-821
[56.]
K. Kuwano, K. Matsuba, T. Ikeda.
The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores.
Am Rev Respir Dis, 141 (1990), pp. 169-178
[57.]
G.H. Guyatt, M. Townsend, L.B. Bermas, S.O. Pugsley.
Quality of life in patients with chronic airflow limitation.
Br J Dis Chest, 81 (1987), pp. 45-54
[58.]
P.W. Jones, F.H. Quirk, C.M. Baveystock, P. Littlejohns.
A selfcomplete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
Am Rev Respir Dis, 145 (1992), pp. 1321-1327
[59.]
R. Güell, P. Casan, M. Sangenis.
Traducción española y validación de un cuestionario de calidad de vida en pacientes con enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 31 (1995), pp. 202-210
[60.]
M. Ferrer, J. Alonso, L. Prieto.
Validity and reliability of the St. George's Respiratory Questionnaire after adaptation to a different language and culture: The Spanish example.
Eur Respir J, 9 (1996), pp. 1160-1166
[61.]
P.W. Jones.
Health status in chronic obstructive pulmonary disease.
Eur Respir Rev, 9 (1999), pp. 169-172
[62.]
N.R. Anthonisen, J.E. Connett, J.P. Kiley, M.D. Altose, W.C. Bailey, S.A. Buist.
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study.
Jama, 272 (1994), pp. 1497-1505
[63.]
C.A. Jiménez, S. Solano, J.M. González de Vega, M.J. Ruiz, P. Flórez, A. Ramos, et al.
Normativa para el tratamiento del tabaquismo.
Arch Bronconeumol, 35 (1999), pp. 499-506
[64.]
C. Silagy, M.D. Fowler, M. Lodge.
Meta-analysis of efficacy of nicotine replacement therapies in smoking cessation.
Lancet, 343 (1994), pp. 139-142
[65.]
T. Blondal, L.J. Gudmundsson, I. Olafsdottir, A. Westin.
Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up.
Brit Med J, 318 (1999), pp. 285-289
[66.]
R.D. Hurt, D.P.L. Sachs, D.E. Glover, K.P. Offord, J.A. Johnston, P.D. Lowell.
A comparison of sustained-release bupropion and placebo for smoking cessation.
N Engl J Med, 337 (1997), pp. 1195-1202
[67.]
D.E. Jorenby, S.J. Leischow, M.A. Nides, S.I. Rennard, J.A. Johnston, A.R. Hughes.
A controlled trial of sustained bupropion, a nicotine patch, or both for smoking cessation.
N Engl J Med, 340 (1999), pp. 685-691
[68.]
S.G. Glurlay, L.F. Stead, N.L. Benowitz.
Clinidine for smoking cessation (Cochrane Review).
The Cochrane Library,
[69.]
Udhhs.
The health consequences of smoking: nicotine addiction: a report of the surgeon general.
Dhhs Cdc 88–8406,
[70.]
A.R. White, H. Rampes.
Acupunture in smoking cessation (Cochrane Review).
The Cochrane Library,
[71.]
K.L. Nichol, K.L. Margolis, J. Wuorenna, T. Von Stember.
The efficacy and cost effectiveness of vaccination agaisnt influenza among elderly persons living in the community.
N Engl J Med, 331 (1994), pp. 778-784
[72.]
A. Örtqvist, J. Hedlund, L.A. Burman, E. Elbel, M. Hófer, M. Leinonen.
Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people.
Lancet, 351 (1998), pp. 399-403
[73.]
N.R. Anthonisen.
OM-85 for COPD.
Am J Respir Crit Care Med, 156 (1997), pp. 1713-1714
[74.]
J. Hay, P. Stone, J. Carter, S. Church.
Bronchodilator reversibility, exercice performance and brethlessness in stable obstructive pulmonary disease.
Eur Respir J, 5 (1992), pp. 659-664
[75.]
J. Fernández, J.L. Izquierdo.
Evaluación de la respuesta broncodilatadora con agonistas beta en pacientes con enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 31 (1995), pp. 270-275
[76.]
P.J. Barnes.
New developments in anticholinergic drugs.
Eur Respir Rev, 6 (1996), pp. 290-294
[77.]
COMBIVENT Inhalation Solution Study Group.
Routine nebulized ipratropium and albuterol together are better than either alone in COPD.
Chest, 112 (1997), pp. 1514-1521
[78.]
M. Cazzola, M.G. Matera.
Should long acting beta-2-agonist be considered an alternative first choice option for the treatment and stable COPD?.
Respir Med, 93 (1999), pp. 227-229
[79.]
S. Appleton, B. Smith, A. Veale, A. Bara.
Regular long-acting beta-2 adrenoceptor agonists in stable chronic obstructive airways disease (Cochrane Review),
[80.]
D.A. Mahler, J.F. Donohue, R.A. Barbee, M.D. Goldman, M.J. Gross, M.E. Wisniewski, et al.
Efficacy of salmeterol xinafoate in the treatment of COPD.
Chest, 115 (1999), pp. 957-965
[82.]
J.W. Jenne.
Teophylline is no more obsolete than two puffs qid of current beta-2 agonists.
Chest, 98 (1990), pp. 3-4
[84.]
D. Murciano, M. Aubier, R. Pariente.
A randomized controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
N Engl J Med, 320 (1989), pp. 1521-1525
[85.]
J. Iravani, G.N. Melville.
Theophylline and mucocilliary function.
Chest, 92 (1987), pp. 38S-48S
[86.]
R.A. Matthay, D.A. Mahler.
Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disesase.
J Allergy Clin Immunol, 78 (1986), pp. 793-799
[87.]
N. Viires, M. Aubier, D. Murciano, B. Fleury, C. Talamo, R. Pariente.
Effects of aminophylline on diaphragmatic fatigue during acute respiratory failure.
Am Rev Respir Dis, 129 (1984), pp. 396-404
[88.]
M. Taccola, L. Cancalari, G. Ghignoni, P.L. Paggiaro.
Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease.
Monaldi Arch Chest Dis, 54 (1999), pp. 302-306
[89.]
J. Ramsdell.
Use of theophylline in the treatment of COPD.
Chest, 107 (1995), pp. 206S-209S
[90.]
J.L. Izquierdo, M. Gutiérrez.
Corticoides inhalados en la EPOC.
Arch Bronconeumol, 35 (1999), pp. 365-366
[91.]
P.S. Burge.
EUROSCOP, ISOLDE and the Copenhagen city lung study.
Thorax, 54 (1999), pp. 287-288
[92.]
J. Vestbo, T. Sorensen, P. Lante, A. Brix, P. Torre, Viskum.
Longterm effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.
Lancet, 353 (1999), pp. 1819-1823
[93.]
R.A. Pauwels, C.G. Lofdahl, L.A. Laitinen, J.P. Schouten, D. Postma, N.B. Pride, et al.
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking.
N Engl J Med, 340 (1999), pp. 1948-1953
[94.]
P.L. Paggiaro, R. Dahle, I. Bakran, L. Frith, K. Hollingworth, J. Efhimiou.
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease.
Lancet, 351 (1998), pp. 773-780
[95.]
P.S. Burge, P.M.A. Calverley, P.W. Jones, S. Spencer, J.A. Anderson, T.K. Maslen.
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.
Brit Med J, 320 (2000), pp. 1297-1303
[96.]
C.M. Callahan, R.S. Dittus, B.P. Katz.
Oral corticosteroid theraphy for patients with stable chronic obstructive pulmonary disease. A meta-analysis.
Ann Intern Med, 114 (1991), pp. 216-223
[97.]
American Thoracic Society.
Guidelines for the approach to the patient with severe hereditary alpha 1-antitripsin deficiency.
Am Rev Respir Dis, 27 (1989), pp. 1494-1497
[98.]
M. Miravitlles, R. Vidal, J.C. Barros-Tizón, A. Bustamente, P.P. España, F. Casas, et al.
Estado actual del tratamiento sustitutivo en el enfisema congénito por déficit de alfa-1-antitripsina. Informe del registro nacional.
Arch Bronconeumol, 35 (1999), pp. 446-454
[99.]
Alpha-1-Antitrypsin Deficiency Registry Study Group.
Survival and FEV1 decline in individuals with severe deficiency of alpha- 1-antitrypsin.
Am J Respir Crit Care Med, 158 (1998), pp. 49-59
[100.]
N. Seersholm, M. Wencker, N. Banik.
Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in pattients with severe hereditary alpha 1-antitrypsin deficiency?.
Eur Respir J, 10 (1997), pp. 2260-2263
[101.]
R. Bhagat, V. Swystun, D.W. Cockcroft.
Clinical trials needed for alpha-1-antitrypsin replacement therapy.
Chest, 108 (1995), pp. 586-595
[102.]
P.A. Bardsley.
Chronic respiratory failure in COPD: is there a place for a respiratory stimulant?.
Thorax, 48 (1993), pp. 781-784
[103.]
P.J. Poole, P. Black.
Mucolytic agents for chronic bronchitis (Cochrane Review).
The Cochrane Library,
[104.]
E.M. Grandjean, P. Berthet, R. Ruffmann, P. Leuenberger.
Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled trials.
Clin Ther, 22 (2000), pp. 209-221
[105.]
M.P. De Lucas, R. Güell, V. Sobradillo, C. Jiménez, M. Sangenis, T. Montemayor, et al.
Normativa sobre la rehabilitación respiratoria.
Arch Bronconeumol, 36 (2000), pp. 257-274
[106.]
R. Güell, P. Casan, J.A. García.
Rehabilitación respiratoria.
Arch Bronconeumol, 30 (1994), pp. 63-113
[107.]
American College of Chest Physicians, American Association of Cardiovascular and Pulmonary Rehabilitation Guidelines Panel.
Pulmonary rehabilitation: Joing ACCP/AACVPR evidence-based guidelines.
Chest, 112 (1997), pp. 1363-1396
[108.]
T. Montemayor, H. Sánchez, F. Ortega.
Rehabilitación respiratoria.
Manual de neumología y cirugía torácica, pp. 619-641
[109.]
J.A. Wedzicha, J.C. Bestall, R. Garrod, R. Tarnham, E.A. Paul, P.W. Jones.
Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale.
Eur Respir J, 12 (1998), pp. 363-369
[110.]
Y. Lacasse, E. Wong, G.H. Guyatt, D. King, D.J. Cook, R.S. Goldstein.
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease.
Lancet,, 348 (1996), pp. 1115-1119
[111.]
W. Cambach, R.C. Wagenaar, T.W. Koelman, A.R. Van Keimpema, H.C. Kemper.
The longterm effects of pulmonary rehabilitation in patients with asthma and chronic obstructive pulmonary disease: a research synthesis. Meta-analysis.
Arch Phys Med Rehabil, 1 (1999), pp. 103-111
[112.]
A.L. Hamilton, K.J. Killian, E. Summers, N.L. Jones.
Muscle strenght, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.
Am J Respir Crit Care Med, 152 (1995), pp. 2021-2031
[113.]
R. Gosselink, T. Troosters, M. Decramer.
Peripheral muscle weakness contributes to exercise limitation in COPD.
Am J Respir Crit Care Med, 153 (1996), pp. 976-980
[114.]
S. Bernard, P. Leblanc, F. Whittom, M.G. Carrier, J. Jobin, R. Belleau, et al.
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 158 (1998), pp. 629-634
[115.]
K. Simpson, K. Killian, N. McCartrey, D.G. Stubbing, N.L. Jones.
Randomised controlled trial of weight-lifting exercise in patients with chronic airflow limitation.
Thorax, 47 (1992), pp. 70-75
[116.]
S. Bernard, F. Whittom, P. Leblanc, J. Jobin, R. Belleau, C.H. Berube, et al.
Aerobic and strenght training in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 159 (1999), pp. 896-901
[117.]
J. Toral, F. Ortega, P. Cejudo, R. Villagómez, H. Sánchez, J. Castillo, et al.
Comparación entre diferentes modalidades de entrenamiento muscular periférico en la rehabilitación de pacientes con EPOC estables.
Arch Bronconeumol, 35 (1999), pp. 1S
[118.]
K. Smith, D. Cook, G.H. Guyatt, J. Madhavan, A.D. Oxman.
Respiratory muscle training in chronic airflow limitation: a metaanalysis.
Am Rev Respir Dis, 145 (1992), pp. 533-539
[119.]
C. Lisboa, V. Muñoz, T. Beroiza, A. Leiva, E. Cruz.
Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads using a threshold device.
Eur Respir J, 7 (1994), pp. 1266-1274
[120.]
P. De Lucas, J.M. Rodrígues González-Moro, J. García de Pedro, A. Santacruz, E. Tatay, J.M. Cubillo.
Entrenamiento de los músculos inspiratorios en la enfermedad pulmonar obstructiva crónica: su repercusión en parámetros funcionales y tolerancia al ejercicio.
Arch Bronconeumol, 34 (1998), pp. 64-70
[121.]
P. Cejudo, H. Sánchez, F. Ortega, J. Toral, R. Villagómez, T. Montemayor.
Home ventilatory muscle training in patients with chronic obstructive pulmonary disease (COPD).
Eur Respir J, 12 (1988), pp. 3S
[122.]
I.M. Ferreira, D. Brooks, Y. Lacasse, R.S. Goldstein.
Nutritional support for individuals with COPD: a meta-analysis.
Chest, 117 (2000), pp. 672-678
[123.]
P.J. Wijkstra, R. Van Altena, J. Kraan, V. Otten, D.S. Postma, G.H. Koeter.
Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation in the home.
Eur Respir J, 7 (1994), pp. 269-273
[124.]
J.H. Strijbos, D.S. Postma, R. Van Altena, F. Gimeno, G.H. Koeter.
A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care rehabilitation program in patients with COPD.
Chest, 109 (1996), pp. 366-372
[125.]
J.H. Gravil, O.A. Al Rawas, M.M. Cotton, U. Flanigan, A. Irvin, R.D. Stevenson.
Home treatment of exarcerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service.
Lancet, 351 (1998), pp. 1853-1855
[126.]
S. Shepperd, D. Harwood, A. Gray, M. Vessey, P. Morgan.
Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis.
Brit Med J, 316 (1998), pp. 1791-1796
[127.]
Medical Research Council Working Party.
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema.
Lancet, 1 (1981), pp. 681-686
[128.]
Nocturnal Oxygen Therapy Group.
Continous or nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease: a clinical trial.
Ann Intern Med, 93 (1980), pp. 391-398
[129.]
L. Sánchez-Agudo, R. Cornudella, R. Estopà, L. Molinos, E. Servera.
Normativa para la indicación y empleo de la oxigenoterapia continua domiciliaria (OCD).
Arch Bronconeumol, 34 (1998), pp. 87-94
[130.]
A. Chaouat, E. Weitzenblum, R. Kessler, C. Charpentier, M. Enrhart, R. Schott, et al.
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients.
Eur Respir J, 14 (1999), pp. 1002-1008
[131.]
F. Smeets.
Travel for technology-dependent patients with respiratory disease.
Thorax, 49 (1994), pp. 77-81
[132.]
J.D. Hosenpud, L.E. Bennett, B.M. Keck, B. Fiol, M.M. Boucek, R.J. Novick.
The Registry of the Internationl Society for Heart and Lung Transplantation: fifteenth official report-1998.
J Heart Lung Transplant, 17 (1998), pp. 656-668
[133.]
E.P. Trulock.
Lung transplantation.
Am J Respir Crit Care Med, 155 (1997), pp. 789-818
[134.]
J.D. Hosenpud, L.E. Bennet, B.M. Keck, E.B. Edwards, R.J. Novick.
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.
Lancet, 351 (1998), pp. 24-27
[135.]
G.A. Patterson, J.R. Maurer, T.J. Williams, P.G. Cardoso, M. Scavuzzo, T.R. Todd.
Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group.
J Thorac Cardiovasc Surg, 101 (1991), pp. 623-631
[136.]
R.D. Levy, P. Ernst, S.M. Levine, H. Shennib, A. Anzueto, C.L. Bryan, et al.
Exercise performance after lung transplantation.
J Heart Lung Transplant, 12 (1993), pp. 27-33
[137.]
C.R. Gross, K. Savik, R.M. Bolman, M.I. Hertz.
Long-term health status and quality of life outcomes of lung transplant recipients.
Chest, 108 (1995), pp. 1587-1593
[138.]
A. Varela, A. Román, P. De Lucas, P. Morales, R. Lama, M.C. Carreño.
Normativa sobre el estudio y seguimiento del receptor de un trasplante pulmonar,
[139.]
J.R. Maurer, A.E. Frost, M. Estenne, T. Higenbottam, A.R. Glanville.
International guidelines for the selection of lung transplant candidates.
J Heart Lung Transplant, 17 (1998), pp. 703-709
[140.]
J.D. Cooper, E.P. Trulock, A.N. Triantafillou, G.A. Patterson, M.S. Pohl, P.A. Deloney, et al.
Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease.
J Thorac Cardiovasc Surg, 109 (1995), pp. 106-116
[141.]
A.M. Fein, S.S. Branman, R. Casaburi, C.G. Irvin, B.J. Make, J.R. Rodarte, et al.
Lung volume reduction surgery.
Am J Respir Crit Care Med, 154 (1996), pp. 1151-1152
[142.]
The National Emphysema Treatment Trial Research Group.
Rationale and design of the National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery.
Chest, 116 (1999), pp. 1750-1761
[143.]
D. Geddes, M. Davies, H. Koyama, D. Hansell, U. Pastorino, J. Pepper, et al.
Effect of lung-volume-reduction surgery in patients with severe emphysema.
N Engl J Med, 343 (2000), pp. 239-245
[144.]
E.W. Russi, U. Stammberger, W. Weder.
Lung volume reduction surgery for emphysema.
Eur Respir J, 10 (1997), pp. 208-218
[145.]
A.F. Gelb, R.J.J. McKenna, M. Brenner, M.J. Schein, N. Zamel, R. Fischel.
Lung function 4 years after lung volume reduction surgery for emphysema.
Chest, 116 (1999), pp. 1608-1615
[146.]
R.M. Slone, T.K. Pilgram, D.S. Gierada, S.S. Sagel, H.S. Glazer, R.D. Yusen, et al.
Lung volume reduction surgery: comparison of preoperative radiologic features and clinical outcome.
Radiology, 204 (1997), pp. 685-693
[147.]
R.D. Yusen, S.S. Lefrak, E.P. Trulock.
Evaluation and preoperative management of lung volume reduction surgery candidates.
Clin Chest Med, 18 (1997), pp. 199-224
[148.]
G.L. Snider.
Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema.
Chest, 109 (1996), pp. 540-548
[149.]
M.C. Marshall, G.N. Olsen.
The physiologic evaluation of the lung resection cadidate.
Clin Chest Med, 14 (1993), pp. 305-320
[150.]
C.T. Bolliger, A.P. Perruchoud.
Functional evaluation of the lung resection candidate.
Eur Respir J, 11 (1998), pp. 198-212
[151.]
J. Markos, B.P. Mullan, D.R. Hillman, A.W. Musk, V.F. Antico, F.T. Lovegrove, et al.
Preoperative assessment as a predictor of mortality and morbility after lung resection.
Am Rev Respir Dis, 139 (1989), pp. 902-910
[152.]
J. Ribas, O. Díaz, J.A. Barberà, M. Mateu, E. Canalis, L. Jover, et al.
Invasive exercise testing in the evaluation of patients at high-risk for lung resection.
Eur Respir J, 12 (1998), pp. 1429-1435
[153.]
R.J. Landreneau, D.J. Surgarbaker, M.J. Mack, S.R. Hazelrigg, J.D. Luketich, L. Fetterman, et al.
Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer.
J Thorac Cardiovasc Surg, 113 (1997), pp. 691-698
[154.]
E.M. Tschernko, S. Hofer, C. Bieglmayer, W. Wisser, W. Haider.
Early postoperative stress: viedo-assisted wedge resection/lobectomy vs conventional axillary thoracotomy.
Chest, 109 (1996), pp. 1636-1642
[155.]
C.T. Bolliger, P. Jordan, M. Soler, P. Stulz, E. Gradel, K. Skarvan, et al.
Exercise capacity as a predictor of postoperative complications in lung resection candidates.
Am J Respir Crit Care Med, 151 (1995), pp. 1472-1480
[156.]
N. Soler, A. Torres, S. Ewig, J. González, R. Celis, M. El-Biary, et al.
Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.
Am J Respir Crit Care Med, 157 (1998), pp. 1498-1505
[157.]
J.T. MacFarlane, A. Colville, A. Guion, R.M. MacFarlane, D.H. Rose.
Prospective study of aetiology and outcome of adult lowerrespiratory tract infections in the community.
Lancet, 341 (1993), pp. 511-514
[158.]
G.J. Huchon, G. Gialdroni-Grassi, P. Leophonte, F. Manresa, T. Schaberg, M. Woodhead.
Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey.
Eur Respir J, 9 (1996), pp. 1590-1595
[159.]
X. Xu, L. Wang.
Association of indoor and outdoor particulate pollution level with chronic respiratory illness.
Am Rev Respir Dis, 148 (1993), pp. 1516-1522
[160.]
D.P. Tashkin, R. Detels, M. Simmons.
The UCLA population studies of chronic obstructive pulmonary disease. XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second.
Am J Respir Crit Care Med, 149 (1994), pp. 1067-1083
[161.]
G.H. Murata, M.S. Gorby, T.W. Chick, A.K. Halperin.
Use of emergency medical services by patients with decompensated obstructive lung disease.
Ann Emerg Med, 18 (1989), pp. 501-506
[162.]
D.S. Postma.
When can an exacerbation of COPD be trated at home?.
Lancet, 351 (1998), pp. 1827-1828
[163.]
N.H. Gross, T.L. Petty, M. Friedman.
Dose-response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 139 (1989), pp. 1185-1191
[164.]
P. Moayyedi, J. Congleton, R.L. Page, S.B. Pearson, M.H. Muers.
Comparison of nebulised salbutamol and ipratropium bromide with salbutamil alone in the treatment of chronic obstructive pulmonary disease.
Thorax, 50 (1995), pp. 834-837
[165.]
N.R. Anthonisen, J. Manfreda, C.P.W. Warren, E.S. Hershfield, G.K. Harding, N.A. Nelson.
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Ann Intern Med, 106 (1987), pp. 196-204
[166.]
S. Saint, S. Bent, E. Wittinghoff.
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis.
Jama, 273 (1995), pp. 957-960
[167.]
P. Ball.
Epidemiology and treatment of chronic bronchitis and its exacerbations.
Chest, 108 (1995), pp. 43S-52S
[168.]
R.K. Albert, T.R. Martin, S.W. Lewis.
Controlled clinical trials of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency.
Ann Intern Med, 92 (1980), pp. 753-758
[169.]
L. Davies, R.M. Angus, P.M. Calverley.
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Lancet, 354 (1999), pp. 456-460
[170.]
D.E. Niewoehner, M.L. Erbland, R.H. Deupree, D. Collins, N.J. Gross, R.W. Light, et al.
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
N Engl J Med, 340 (1999), pp. 1941-1947
[171.]
C.L. Emerman, D. Effron, T.W. Lukens.
Spirometric criteria for hospital admission of patients with acute exacerbation of COPD.
Chest, 99 (1991), pp. 595-599
[172.]
R. Kessler, M. Faller, G. Fourgaut, B. Mennecier, E. Weitzenblum.
Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 159 (1999), pp. 158-164
[173.]
A.F.J. Connors, N.V. Dawson, C. Thomas.
Outcomes following acute exacerbations of severe chronic obstructive lung disease.
Am J Respir Crit Care Med, 154 (1996), pp. 959-967
[174.]
J.A. Barberà, J. Roca, A. Ferrer, M.A. Félez, O. Díaz, N. Roger, et al.
Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease.
Eur Respir J, 10 (1997), pp. 1285-1291
[175.]
A.G.N. Agustí, M. Carrera, F. Barbé, A. Muñoz, B. Togores.
Oxygen therapy during exacerbations of chronic obstructive pulmonary disease.
Eur Respir J, 14 (1999), pp. 934-939
[176.]
M. Aubier, D. Murciano, M. Fournier, J. Milic-Emili, R. Pariente, J.P. Derenne.
Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 122 (1980), pp. 191-200
[177.]
M. Aubier, D. Murciano, J. Milic-Emili, E. Touaty, J. Daghfous, R. Pariente, et al.
Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure.
Am Rev Respir Dis, 122 (1980), pp. 747-754
[178.]
J. Bott, M.P. Carroll, J.H. Conway, S.E.J. Keilty, E.M. Ward, A.M. Brown, et al.
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.
Lancet, 341 (1993), pp. 1555-1557
[179.]
L. Brochard, J. Mancebo, M. Wysocki, F. Lofaso, G. Conti, A. Rauss, et al.
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
N Engl J Med, 333 (1995), pp. 817-822
[180.]
N. Kramer, T.J. Meyer, J. Meharg, R.D. Cece, N.S. Hill.
Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure.
Am J Respir Crit Care Med, 151 (1995), pp. 1799-1806
[181.]
F. Barbé, B. Togores, M. Rubí, S. Pons, A. Maimó, A.G.N. Agustí.
Non-invasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease.
Eur Respir J, 9 (1996), pp. 1240-1245
[182.]
S. Nava, N. Ambrosino, E. Clini, M. Prato, G. Orlando, M. Vitacca, et al.
Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial.
Ann Intern Med, 128 (1998), pp. 721-728
Copyright © 2001. Sociedad Española de Neumología y Cirugía Torácica
